Acalabrutinib maleate is the maleate salt form of acalabrutinib, an orally available inhibitor of Bruton's tyrosine kinase (BTK). It is a pharmaceutical raw material used in the manufacturing of compounds that target B-cell receptor signaling pathways for research purposes.
콘텐츠 범위: 이 페이지의 정보는 화학물질 식별 및 산업 공급·연구개발·제조 맥락을 대상으로 합니다. 치료 효능 주장, 의료 조언 또는 의약품 사용 지침에 해당하지 않습니다.
이 화합물을 구매하거나 공급하시겠습니까?
재고를 등록하거나 구매 요청을 게시하세요
CAS 2242394-65-4
Acalabrutinib maleate monohydrate
active pharmaceutical ingredient
Acalabrutinib
Bruton's tyrosine kinase inhibitor
Pirtobrutinib
Bruton's tyrosine kinase inhibitor
Ginsenoside RG1
active pharmaceutical ingredient
Acoramidis hydrochloride
transthyretin stabilizer active pharmaceutical ingredient
Retapamulin
topical antibiotic active pharmaceutical ingredient
Calcium orotate
active pharmaceutical ingredient
Acalabrutinib D4
active pharmaceutical ingredient
4-[8-amino-3-[(2S)-1-but-2-ynoylpyrrolidin-2-yl]imidazo[1,5-a]pyrazin-1-yl]-N-pyridin-2-ylbenzamide;(Z)-but-2-enedioic acid
JWEQLWMZHJSMEC-AFJTUFCWSA-N
CC#CC(=O)N1CCC[C@H]1C2=NC(=C3N2C=CN=C3N)C4=CC=C(C=C4)C(=O)NC5=CC=CC=N5.C(=C\C(=O)O)\C(=O)O